Jenburkt Pharmaceuticals Ltd
BSE:524731

Watchlist Manager
Jenburkt Pharmaceuticals Ltd Logo
Jenburkt Pharmaceuticals Ltd
BSE:524731
Watchlist
Price: 1 277.55 INR 4.03% Market Closed
Market Cap: 5.6B INR

Jenburkt Pharmaceuticals Ltd
Other Long-Term Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Jenburkt Pharmaceuticals Ltd
Other Long-Term Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Long-Term Assets CAGR 3Y CAGR 5Y CAGR 10Y
Jenburkt Pharmaceuticals Ltd
BSE:524731
Other Long-Term Assets
â‚ą303.4m
CAGR 3-Years
514%
CAGR 5-Years
135%
CAGR 10-Years
N/A
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Other Long-Term Assets
â‚ą18.6B
CAGR 3-Years
24%
CAGR 5-Years
13%
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Other Long-Term Assets
â‚ą8.3B
CAGR 3-Years
-8%
CAGR 5-Years
2%
CAGR 10-Years
19%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Other Long-Term Assets
â‚ą46.8B
CAGR 3-Years
11%
CAGR 5-Years
4%
CAGR 10-Years
13%
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Other Long-Term Assets
â‚ą6.1B
CAGR 3-Years
13%
CAGR 5-Years
7%
CAGR 10-Years
15%
M
Mankind Pharma Ltd
NSE:MANKIND
Other Long-Term Assets
â‚ą1.1B
CAGR 3-Years
26%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

Jenburkt Pharmaceuticals Ltd
Glance View

Market Cap
5.6B INR
Industry
Pharmaceuticals

Jenburkt Pharmaceuticals Ltd. engages in the manufacture and marketing of pharmaceutical formulations and healthcare products. The company is headquartered in Mumbai, Maharashtra and currently employs 730 full-time employees. The firm offers pharmaceutical products for various therapeutic areas, analgesic and antipyretics anthelmintics, anti-arthritic, anti-diabetics, anti-infectives, antifungals, antimalarials, antiulcerants/antacids, aphrodisiac, consumer division, cough and cold, muscle relaxants neuropathic pain, nutraceuticals and pain management. The firm's product brands include Allerzine tablets, Cartisafe forte MSM tablets, Eberjen Cream and SOL, ECOPROT powder, Frendacid suspension, Fundu tablets, Glajen-E capsules, GLUCOTROL tablets, Jenflam tablets, Lutriben cream, Ornel tablets, Pantazole tablets and others. The firm's manufacturing plant is located in Sihor-Gujarat. The firm's products are exported to approximately 13 countries globally.

JENBURPH Intrinsic Value
786.24 INR
Overvaluation 38%
Intrinsic Value
Price

See Also

What is Jenburkt Pharmaceuticals Ltd's Other Long-Term Assets?
Other Long-Term Assets
303.4m INR

Based on the financial report for Sep 30, 2024, Jenburkt Pharmaceuticals Ltd's Other Long-Term Assets amounts to 303.4m INR.

What is Jenburkt Pharmaceuticals Ltd's Other Long-Term Assets growth rate?
Other Long-Term Assets CAGR 5Y
135%

Over the last year, the Other Long-Term Assets growth was 41%. The average annual Other Long-Term Assets growth rates for Jenburkt Pharmaceuticals Ltd have been 514% over the past three years , 135% over the past five years .

Back to Top